why does tirzepatide have less side effects Retatrutide vs (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness Tirzepatide vs. Semaglutide: Side Effect

urine was collected 180 minutes following gavage ( n = 1522)

The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course

Preventing Chronic Disease, 21, E21

As it doesnt have FDA approval, it may have limited availability

In patient reviews of Zepbound, many users report significant weight loss and changes in their appetite and food cravings